Clinical trials
Phase 2 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
290 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2005 | 4 |
| 2006 | 8 |
| 2007 | 4 |
| 2008 | 8 |
| 2009 | 9 |
| 2010 | 3 |
| 2011 | 15 |
| 2012 | 11 |
| 2013 | 5 |
| 2014 | 6 |
| 2015 | 9 |
| 2016 | 10 |
| 2017 | 22 |
| 2018 | 17 |
| 2019 | 15 |
| 2020 | 11 |
| 2021 | 32 |
| 2022 | 15 |
| 2023 | 13 |
| 2024 | 25 |
| 2025 | 25 |
| 2026 | 16 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 154 |
| Recruiting | 50 |
| Unknown status | 25 |
| Active, not recruiting | 19 |
| Terminated | 18 |
| Withdrawn | 10 |
| Not yet recruiting | 8 |
| Enrolling by invitation | 4 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Wake Forest University Health Sciences | 7 |
| Johns Hopkins University | 6 |
| Chang Gung Memorial Hospital | 5 |
| Mayo Clinic | 5 |
| Columbia University | 4 |
| Eli Lilly and Company | 4 |
| Supernus Pharmaceuticals, Inc. | 4 |
| University of Arizona | 4 |
| University of Washington | 4 |
| Vanderbilt University Medical Center | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 290 |
| Alzheimer Disease | 125 |
| Dementia | 42 |
| Memory Disorders | 19 |
| Cognition Disorders | 14 |
| Inflammation | 12 |
| Neurodegenerative Diseases | 12 |
| Schizophrenia | 12 |
| Brain Diseases | 11 |
| Delirium | 10 |
Trials
Showing 51 to 75 of 290. Each trial links to its page on Pharma Observatory.
190 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.